4.6 Article

A Critical Role of the mTOR/eIF2α Pathway in Hypoxia-Induced Pulmonary Hypertension

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice

Pengpeng Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Article Cell Biology

mTORC1 Is Involved in Hypoxia-Induced Pulmonary Hypertension Through the Activation of Notch3

Wang Wang et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2014)

Article Multidisciplinary Sciences

Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression

Maimon E. Hubbi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Physiology

Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells

Jun Yang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)

Article Biochemistry & Molecular Biology

Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension

Amal Houssaini et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)

Review Biochemistry & Molecular Biology

mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects

Elena A. Goncharova

FASEB JOURNAL (2013)

Article Biochemistry & Molecular Biology

mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia

Vera P. Krymskaya et al.

FASEB JOURNAL (2011)

Review Cardiac & Cardiovascular Systems

Vascular remodeling in pulmonary arterial hypertension: Multiple cancer-like pathways and possible treatment modalities

Seiichiro Sakao et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)

Article Biochemistry & Molecular Biology

mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells

Elena A. Goncharova et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Article Oncology

Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells

Tongrui Liu et al.

MOLECULAR CANCER THERAPEUTICS (2011)

Article Critical Care Medicine

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension

Bhola Kumar Dahal et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Article Biochemistry & Molecular Biology

Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27Kip1

Stephanie C. Moss et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Cardiac & Cardiovascular Systems

Cellular and Molecular Basis of Pulmonary Arterial Hypertension

Nicholas W. Morrell et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Review Cardiac & Cardiovascular Systems

Pathogenic mechanisms of pulmonary arterial hypertension

Stephen Y. Chan et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)

Article Physiology

Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension

Fares A. Masri et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)

Article Biochemistry & Molecular Biology

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

DD Sarbassov et al.

MOLECULAR CELL (2006)

Article Biochemistry & Molecular Biology

mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin

Thurl E. Harris et al.

EMBO JOURNAL (2006)